+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Screening - Global Market Trajectory & Analytics

  • ID: 4804177
  • Report
  • May 2020
  • Region: Global
  • 180 pages
  • Global Industry Analysts, Inc
1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Drug Screening market worldwide will grow by a projected US$5 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 8.8%. Products, one of the segments analyzed and sized in this study, is forecast to grow at over 7.9% and reach a market size of US$7.5 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Products market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 10.3% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$227.8 Million to the region's size over the next 7 to 8 years. In addition, over US$225.6 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Products segment will reach a market size of US$489.6 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Drug Screening market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 8.9% over the next couple of years and add approximately US$768.3 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Drug Screening market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Alere, Inc, Alfa Scientific Designs, Inc, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings (LabCorp), Lifeloc Technologies, Inc, Mpd, Inc, Omega Laboratories, Inc, OraSure Technologies, Inc, Premier Biotech, Inc, Psychemedics Corporation, Quest Diagnostics, Inc, Shimadzu Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Drug Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Drug Screening Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Drug Screening Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Drug Screening Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Products (Component) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Products (Component) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Products (Component) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Services (Component) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: Services (Component) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: Services (Component) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Urine (Sample Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Urine (Sample Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Urine (Sample Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Breath (Sample Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: Breath (Sample Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: Breath (Sample Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Oral Fluid (Sample Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 17: Oral Fluid (Sample Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 18: Oral Fluid (Sample Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Hair (Sample Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
TABLE 20: Hair (Sample Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 21: Hair (Sample Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
TABLE 22: Other Sample Types (Sample Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
TABLE 23: Other Sample Types (Sample Type) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
TABLE 24: Other Sample Types (Sample Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Drug Screening Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 25: United States Drug Screening Market Estimates and Projections in US$ Million by Component: 2020 to 2027
TABLE 26: Drug Screening Market in the United States by Component: A Historic Review in US$ Million for 2012-2019
TABLE 27: United States Drug Screening Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 28: United States Drug Screening Market Estimates and Projections in US$ Million by Sample Type: 2020 to 2027
TABLE 29: Drug Screening Market in the United States by Sample Type: A Historic Review in US$ Million for 2012-2019
TABLE 30: United States Drug Screening Market Share Breakdown by Sample Type: 2012 VS 2020 VS 2027
CANADA
TABLE 31: Canadian Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2020 to 2027
TABLE 32: Canadian Drug Screening Historic Market Review by Component in US$ Million: 2012-2019
TABLE 33: Drug Screening Market in Canada: Percentage Share Breakdown of Sales by Component for 2012, 2020, and 2027
TABLE 34: Canadian Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2020 to 2027
TABLE 35: Canadian Drug Screening Historic Market Review by Sample Type in US$ Million: 2012-2019
TABLE 36: Drug Screening Market in Canada: Percentage Share Breakdown of Sales by Sample Type for 2012, 2020, and 2027
JAPAN
TABLE 37: Japanese Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2020-2027
TABLE 38: Drug Screening Market in Japan: Historic Sales Analysis in US$ Million by Component for the Period 2012-2019
TABLE 39: Japanese Drug Screening Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 40: Japanese Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Sample Type for the Period 2020-2027
TABLE 41: Drug Screening Market in Japan: Historic Sales Analysis in US$ Million by Sample Type for the Period 2012-2019
TABLE 42: Japanese Drug Screening Market Share Analysis by Sample Type: 2012 VS 2020 VS 2027
CHINA
TABLE 43: Chinese Drug Screening Market Growth Prospects in US$ Million by Component for the Period 2020-2027
TABLE 44: Drug Screening Historic Market Analysis in China in US$ Million by Component: 2012-2019
TABLE 45: Chinese Drug Screening Market by Component: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 46: Chinese Drug Screening Market Growth Prospects in US$ Million by Sample Type for the Period 2020-2027
TABLE 47: Drug Screening Historic Market Analysis in China in US$ Million by Sample Type: 2012-2019
TABLE 48: Chinese Drug Screening Market by Sample Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Drug Screening Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 49: European Drug Screening Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 50: Drug Screening Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 51: European Drug Screening Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 52: European Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2020-2027
TABLE 53: Drug Screening Market in Europe in US$ Million by Component: A Historic Review for the Period 2012-2019
TABLE 54: European Drug Screening Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 55: European Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2020-2027
TABLE 56: Drug Screening Market in Europe in US$ Million by Sample Type: A Historic Review for the Period 2012-2019
TABLE 57: European Drug Screening Market Share Breakdown by Sample Type: 2012 VS 2020 VS 2027
FRANCE
TABLE 58: Drug Screening Market in France by Component: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 59: French Drug Screening Historic Market Scenario in US$ Million by Component: 2012-2019
TABLE 60: French Drug Screening Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 61: Drug Screening Market in France by Sample Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 62: French Drug Screening Historic Market Scenario in US$ Million by Sample Type: 2012-2019
TABLE 63: French Drug Screening Market Share Analysis by Sample Type: 2012 VS 2020 VS 2027
GERMANY
TABLE 64: Drug Screening Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2020-2027
TABLE 65: German Drug Screening Historic Market Analysis in US$ Million by Component: 2012-2019
TABLE 66: German Drug Screening Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 67: Drug Screening Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Sample Type for the Period 2020-2027
TABLE 68: German Drug Screening Historic Market Analysis in US$ Million by Sample Type: 2012-2019
TABLE 69: German Drug Screening Market Share Breakdown by Sample Type: 2012 VS 2020 VS 2027
ITALY
TABLE 70: Italian Drug Screening Market Growth Prospects in US$ Million by Component for the Period 2020-2027
TABLE 71: Drug Screening Historic Market Analysis in Italy in US$ Million by Component: 2012-2019
TABLE 72: Italian Drug Screening Market by Component: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 73: Italian Drug Screening Market Growth Prospects in US$ Million by Sample Type for the Period 2020-2027
TABLE 74: Drug Screening Historic Market Analysis in Italy in US$ Million by Sample Type: 2012-2019
TABLE 75: Italian Drug Screening Market by Sample Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
TABLE 76: United Kingdom Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2020-2027
TABLE 77: Drug Screening Market in the United Kingdom: Historic Sales Analysis in US$ Million by Component for the Period 2012-2019
TABLE 78: United Kingdom Drug Screening Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 79: United Kingdom Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Sample Type for the Period 2020-2027
TABLE 80: Drug Screening Market in the United Kingdom: Historic Sales Analysis in US$ Million by Sample Type for the Period 2012-2019
TABLE 81: United Kingdom Drug Screening Market Share Analysis by Sample Type: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 82: Rest of Europe Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2020-2027
TABLE 83: Drug Screening Market in Rest of Europe in US$ Million by Component: A Historic Review for the Period 2012-2019
TABLE 84: Rest of Europe Drug Screening Market Share Breakdown by Component: 2012 VS 2020 VS 2027
TABLE 85: Rest of Europe Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2020-2027
TABLE 86: Drug Screening Market in Rest of Europe in US$ Million by Sample Type: A Historic Review for the Period 2012-2019
TABLE 87: Rest of Europe Drug Screening Market Share Breakdown by Sample Type: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 88: Drug Screening Market in Asia-Pacific by Component: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 89: Asia-Pacific Drug Screening Historic Market Scenario in US$ Million by Component: 2012-2019
TABLE 90: Asia-Pacific Drug Screening Market Share Analysis by Component: 2012 VS 2020 VS 2027
TABLE 91: Drug Screening Market in Asia-Pacific by Sample Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 92: Asia-Pacific Drug Screening Historic Market Scenario in US$ Million by Sample Type: 2012-2019
TABLE 93: Asia-Pacific Drug Screening Market Share Analysis by Sample Type: 2012 VS 2020 VS 2027
REST OF WORLD
TABLE 94: Rest of World Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2020 to 2027
TABLE 95: Rest of World Drug Screening Historic Market Review by Component in US$ Million: 2012-2019
TABLE 96: Drug Screening Market in Rest of World: Percentage Share Breakdown of Sales by Component for 2012, 2020, and 2027
TABLE 97: Rest of World Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2020 to 2027
TABLE 98: Rest of World Drug Screening Historic Market Review by Sample Type in US$ Million: 2012-2019
TABLE 99: Drug Screening Market in Rest of World: Percentage Share Breakdown of Sales by Sample Type for 2012, 2020, and 2027

IV. COMPETITION
Total Companies Profiled: 42
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll